Oaktree Acquisition Corp. III Life Sciences OACC
10.70 USD -0.05 (-0.47%)
At closeNov 5, 2026, 4:00 PM EST
10.75 +0.05 +0.47%
After hours · Nov 5, 4:00 PM ET
10.70 Day range 10.70
10.50 52-week range 10.93
- YTD
- +1.13%
- 1 year
- +0.94%
Financial health
Altman Z-Score
17.97 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
B3 / 5 overall
- DCF 1
- Return on Equity 2
- Return on Assets 5
- Debt / Equity 5
- P/E 1
- P/B 3
Valuation
P/E 35.3×
FY 2024 5y median 110× FY 2025
P/S 0.0×
FY 2024 5y median 0.0× FY 2025
P/B 1.0×
FY 2024 5y median 1.2× FY 2025
P/FCF -481×
FY 2024 5y median -684163× FY 2025
EV/EBITDA -169×
FY 2024 5y median 88.9× FY 2025
EV/Sales 0.0×
FY 2024 5y median 0.0× FY 2025
FCF Yield -0.2%
FY 2024 5y median -0.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2024 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2024 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2024 5y median 0.0% FY 2025
ROE 3.7%
FY 2024 5y median 1.9% FY 2025
ROIC -0.6%
FY 2024 5y median -0.3% FY 2025
ROA 3.6%
FY 2024 5y median 1.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2024 FY 2025
Operating Income -169983.5%
FY 2024 FY 2025
EPS (diluted) 453.5%
FY 2024 FY 2025
Free Cash Flow -235698.3%
FY 2024 FY 2025
Financial Health
Current Ratio 1.2×
FY 2024 5y median 1.7× FY 2025
Quick Ratio 1.2×
FY 2024 5y median 1.7× FY 2025
Debt / Equity 0.0×
FY 2024 5y median 0.0× FY 2025
Net Debt / EBITDA 1.2×
FY 2024 5y median -0.4× FY 2025
Interest Coverage 0.0×
FY 2024 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2024 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2024 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31